Market Currents
Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened...
-
Tuesday, December 13, 2011, 2:03 PM ETEnzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened Y/Y, as royalty payments declined and operating expenses jumped 11% due to higher SG&A expenses.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
